- Home
- NVFY vs BCAB Comparison
NVFY vs BCAB Comparison
Compare NVFY & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- BCAB
- Stock Information
- Founded
- NVFY 2003
- BCAB 2007
- Country
- NVFY United States
- BCAB United States
- Employees
- NVFY N/A
- BCAB N/A
- Industry
- NVFY Home Furnishings
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- NVFY Consumer Discretionary
- BCAB Health Care
- Exchange
- NVFY Nasdaq
- BCAB Nasdaq
- Market Cap
- NVFY 18.8M
- BCAB 21.0M
- IPO Year
- NVFY N/A
- BCAB 2020
- Fundamental
- Price
- NVFY $1.77
- BCAB $0.37
- Analyst Decision
- NVFY
- BCAB Hold
- Analyst Count
- NVFY 0
- BCAB 3
- Target Price
- NVFY N/A
- BCAB $1.00
- AVG Volume (30 Days)
- NVFY 132.1K
- BCAB 639.1K
- Earning Date
- NVFY 08-26-2025
- BCAB 08-07-2025
- Dividend Yield
- NVFY N/A
- BCAB N/A
- EPS Growth
- NVFY N/A
- BCAB N/A
- EPS
- NVFY N/A
- BCAB N/A
- Revenue
- NVFY $9,813,990.00
- BCAB $11,000,000.00
- Revenue This Year
- NVFY N/A
- BCAB N/A
- Revenue Next Year
- NVFY N/A
- BCAB N/A
- P/E Ratio
- NVFY N/A
- BCAB N/A
- Revenue Growth
- NVFY N/A
- BCAB N/A
- 52 Week Low
- NVFY $0.39
- BCAB $0.24
- 52 Week High
- NVFY $3.59
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- NVFY 42.09
- BCAB 49.36
- Support Level
- NVFY $1.79
- BCAB $0.34
- Resistance Level
- NVFY $1.95
- BCAB $0.40
- Average True Range (ATR)
- NVFY 0.26
- BCAB 0.03
- MACD
- NVFY -0.10
- BCAB 0.00
- Stochastic Oscillator
- NVFY 5.22
- BCAB 58.73
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.